KALA BIO, Inc. (KALA)
$0.80-2.44%Close
BUYCRISIS · day 3
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $18M
- Avg volume
- 119.6K
- Beta
- -2.28
- P/E (TTM)
- -0.04
- Short % float
- 1.48%
- Days to cover
- 2.4
- SI change
- +8.9%
- 1W
- -12.09%
- 1M
- +26.98%
- 3M
- -67.08%
- YTD
- -97.42%
- vs SPY 1W
- -10.90%
- vs SPY 1M
- +23.66%
- vs SPY 3M
- -69.47%
- vs SPY YTD
- -109.18%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- SYBUYSo-Young International Inc.RECOVERYQ -7$2.35+2.62%
- TXGBUY10x Genomics, Inc.BULLQ 9$63.80-2.03%
- UPBBUYUpstream Bio, Inc.CRISISQ -28$6.61-5.16%
- FLGTBUYFulgent Genetics, Inc.RECOVERYQ 12$19.45-2.26%
- FTRESELLFortrea Holdings Inc.BEARQ -4$18.31-0.44%
- KZIABUYKazia Therapeutics LimitedRECOVERYQ 5$13.20-1.57%
- PMCBSELLPharmaCyte Biotech, Inc.CRISISQ -3$0.53+0.00%
- AIRSSELLAirSculpt Technologies, Inc.CRISISQ -11$2.64-3.65%
- IMNNSELLImunon, Inc.RECOVERYQ -5$1.59-3.05%
- TELASELLTELA Bio, Inc.CRISISQ -22$0.65+0.00%
- TCRXSELLTScan Therapeutics, Inc.RECOVERYQ -14$0.80+2.56%
- DRUGBUYBright Minds Biosciences Inc.RECOVERYQ 24$77.03-0.50%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 9
- VALUE
- 9
- GROWTH
- 39
- GARP
- 0
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-133.4%
REV YoY-
ROE-222.3%
EPS YoY-
ROA-95.3%
GROSS0
OP0
NET0
[VALUATION]
P/E TTM-0.04
P/E FWD-
SECTOR PE22.66
INDUSTRY PE17.07
P/B6.52
P/FCF-
EV/EBITDA-1.70
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E-
ALTMAN Z-
CURR RATIO6.88
ND/EBITDA-
BETA-2.28
